Ardelyx logo

Ardelyx

A biopharmaceutical company developing oral therapeutics for the treatment of mineral metabolism and metabolic disorders

1

Funding Rounds

$30.0m

Money raised

Overview

A biopharmaceutical company developing oral therapeutics for the treatment of mineral metabolism and metabolic disorders

Funding series

Funding Series Analysis

The company Ardelyx has raised a total of $30m in funding over 1 rounds.

Key Insights:

  • Ardelyx Series B round: $30m
Ardelyx logo
Ardelyx Series B round $30m